Significance of functional hepatic resection rate calculated using 3D CT/99mTc-galactosyl human serum albumin single-photon emission computed tomography fusion imaging

Table 1 Baseline characteristics of patients (n = 57) n (%)

Age mean (range)	65.7 (34-82)
Men/women	33/24
HBsAg positivity	10 (1.6)
HCV positivity	7 (1.2)
Diagnosis
HCC	26 (45.6)
Hilar cholangiocarcinoma	12 (21.1)
Intrahepatic cholangiocarcinoma	6 (10.5)
Metastatic tumor	4 (7.0)
Hemangioma	4 (7.0)
Others	5 (8.8)
Child-Pugh score (5/6/7/8)	44/8/3/2
Child-Pugh classification (A/B)	52/5
ICGR15, mean (range)	10.8 (1.5-44.3)
LHL15, mean (range)	0.920 (0.712-0.973)
Preoperative therapies	18 (31.6)
TACE	6 (10.5)
Radiation	5 (8.8)
RFA	3 (5.3)
Partial resection	3 (5.3)
Chemotherapy	1 (1.8)
Tumor size > 1000 mL	5 (8.8)
Portal vein thrombosis	8 (14.0)
Hepatic vein thrombosis	3 (5.3)
Preoperative biliary drainage	15 (26.3)
Preoperative portal vein embolization	13 (22.8)

HCC: Hepatocellular carcinoma; ICGR₁₅: Indocyanine green retention at 15 min; LHL₁₅: The hepatic uptake ratio to the liver plus heart at 15 min of ^99mTc-galactosyl human serum albumin; TACE: Transcatheter arterial chemoembolization; RFA: Radiofrequency ablation.